Ph. Maillard
Curie Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ph. Maillard.
Bioorganic & Medicinal Chemistry | 2003
I Laville; T Figueiredo; B Loock; S Pigaglio; Ph. Maillard; David S. Grierson; Danièle Carrez; Alain Croisy; Jean-Claude Blais
Glucoconjugated tri and tetra(meta-hydroxyphenyl)chlorins have been synthesized in order to explore how glucoconjugation of the macrocycle affects the photoactivity of the molecule. Internalization processes, photosensitizing efficacy of TPC(m-O-GluOH)(3) and TPC(m-O-GluOH)(4), in HT29 human adenocarcinoma cells have been compared to those of tetra(meta-hydroxyphenyl) chlorin (m-THPC, Foscan). The tetra glucoconjugated chlorin, TPC(m-O-GluOH)(4), was found to be poorly internalized and weakly photoactive. In contrast, the asymmetric and more amphiphilic compound TPC(m-O-GluOH)(3), exhibited superior phototoxicity compared to m-THPC. Drug concentration, temperature and sodium azide effects indicated that TPC(m-O-GluOH)(3) internalization partly proceeds via an active receptor-mediated endocytosis mechanism. Cellular uptake appeared as a saturable process and remained 30% lower than for mTHPC. However, a maximum phototoxicity in HT29 cells (survival fraction of 2+/-0.6%) were observed for concentration as low as 2 microM. A 4-fold higher concentration of m-THPC was necessary to observe the same level of photoactivity. This higher phototoxicity has been correlated to a greater mitochondrial affinity. On the basis of these results, work is in progress to further evaluate the potential of glycosylated chlorins in photodynamic therapy (PDT).
Journal of Photochemistry and Photobiology B-biology | 2003
R.F. Turchiello; F.C.B. Vena; Ph. Maillard; C.S. Souza; M.V.B.L. Bentley; Antonio C. Tedesco
The ability of the cubic liquid-crystalline phase to incorporate and control the release of drugs of varying size and polar characteristics makes it an interesting candidate as a drug delivery system. In the present study we investigated a new potential application of the cubic phase (monoolein/water; 70:30, w/w) to deliver pro-drugs and a photosensitizer for topical application in photodynamic therapy (PDT). Therefore the pro-drug 5-aminolevulinic acid (5-ALA, a PpIX precursor), its ester derivatives (hexylester, octylester and decylester), and the chlorine compound meso-tetra(hydroxyphenyl)chlorine (m-THPC) were incorporated into the cubic phase gel of monoolein/water and their physicochemical and spectroscopic properties were investigated at 37 degrees C. Drug stability was monitored for short and long periods of time. 5-ALA and its ester derivatives as non-fluorescent probes had their properties studied after chemical reaction leading to a fluorescent derivative. For all the compounds analyzed in this study the spectroscopic properties were clearly defined with potential photodynamic activity in the gel formulation. We are currently evaluating the potential of monoolein/water as a drug delivery system in the treatment of different cutaneous diseases and other PDT applications.
Tetrahedron Letters | 1991
Ph. Maillard; J.L. Guerquin-Kern; Michel Momenteau
Abstract The catalytic properties of new family of tetrapyrrolic macrocycles containing some glycosylated groups are described. Of particular interest is the structure of the catalysts.
Tetrahedron Letters | 1992
Ph. Maillard; C. Huel; Michel Momenteau
Abstract The synthesis of a new family of meso-tetrakis (glycosylated) porphyrins is reported. Unfortunately, the porphyrins 4 and 5 bearing glycosyloxymethylene substituents are unstable.
Annales pharmaceutiques françaises | 2008
P. Prognon; A. Kasselouri; M. Desroches; J. Blais; Ph. Maillard
The macrocyclic tetrapyrrole derivatives used for the treatment of certain solid tumors include porphyrins and their chlorine and bacteriochlorin derivatives. These are highly conjugated, rigid molecules characterized by a strong absorbance in the spectral domain from near ultra-violet to far red (350-750 nm). The combination of tetrapyrroles plus light is called dynamic phototherapy (DPT). This combination transforms the molecule to its triplet form which by deactivation generates free radicals and a singlet oxygen from molecular oxygen, causing tumor destruction. Tetrapyrroles are thus, with psoralens, used for the treatment of psoriasis. They are the only drugs whose mechanism of action results exclusively from their electronic and photophysical spectroscopic characteristics. This class of anticancer agents is usually free of any specific cytotoxic effect. We describe here the current elements linking structure and spectroscopy and observations leading to the design of compounds with strong tumor selectivity and optimal cytotoxic properties.
Tetrahedron | 1987
S. Gaspard; Ph. Maillard
Photodiagnosis and Photodynamic Therapy | 2007
Ph. Maillard; Bernard Loock; David S. Grierson; I Laville; Jocelyne Blais; F. Doz; L. Desjardins; Danièle Carrez; J.L. Guerquin-Kern; Alain Croisy
Bioorganic & Medicinal Chemistry | 2004
I Laville; S Pigaglio; Jean-Claude Blais; B Loock; Ph. Maillard; David S. Grierson; J Blais
Photodiagnosis and Photodynamic Therapy | 2017
J.-O. Durand; Magali Gary-Bobo; Ph. Maillard; Mireille Blanchard-Desce; Alain Morère; Marcel Garcia; Laurence Raehm
Photodiagnosis and Photodynamic Therapy | 2017
Véronique Rosilio; K. Daghildjian; Jean-Philippe Michel; A. Kasselouri; Florent Poyer; Ph. Maillard